• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Advocacy for renal replacement therapy: the role of renal registries.肾脏替代治疗的宣传:肾脏登记处的作用。
Clin Kidney J. 2020 Jul 29;13(5):742-744. doi: 10.1093/ckj/sfaa067. eCollection 2020 Oct.
2
Epidemiological Transition of End-Stage Kidney Disease in Oman.阿曼终末期肾病的流行病学转变
Kidney Int Rep. 2016 Sep 14;2(1):27-35. doi: 10.1016/j.ekir.2016.09.001. eCollection 2017 Jan.
3
Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.IgA 肾病患者终末期肾病的长期预后:一项多中心注册研究。
Nephrology (Carlton). 2016 May;21(5):387-96. doi: 10.1111/nep.12629.
4
End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.因 Alport 综合征导致的终末期肾病:296 例澳大利亚和新西兰透析和移植登记处连续病例的结局。
Nephrol Dial Transplant. 2014 Dec;29(12):2277-86. doi: 10.1093/ndt/gfu254. Epub 2014 Jul 24.
5
Estimating the total prevalence and incidence of end-stage kidney disease among Aboriginal and non-Aboriginal populations in the Northern Territory of Australia, using multiple data sources.利用多个数据源估算澳大利亚北领地原住民和非原住民人群终末期肾病的总患病率和发病率。
BMC Nephrol. 2018 Jan 15;19(1):15. doi: 10.1186/s12882-017-0791-3.
6
Hemodialysis血液透析
7
Incidence and survival of end-stage kidney disease due to polycystic kidney disease in Australia and New Zealand (1963-2014).澳大利亚和新西兰多囊肾病所致终末期肾病的发病率及生存率(1963 - 2014年)
Popul Health Metr. 2017 Feb 17;15(1):7. doi: 10.1186/s12963-017-0123-7.
8
Access to and coverage of renal replacement therapy in minorities and ethnic groups in Venezuela.委内瑞拉少数群体和族裔群体获得肾脏替代治疗的情况及覆盖范围。
Kidney Int Suppl. 2005 Aug(97):S18-22. doi: 10.1111/j.1523-1755.2005.09703.x.
9
Secular trends in end-stage kidney disease requiring renal replacement therapy in Japan: Japanese Society of Dialysis Therapy Registry data from 1983 to 2016.日本终末期肾病接受肾脏替代治疗患者的流行趋势:1983 年至 2016 年日本透析治疗登记协会数据。
Nephrology (Carlton). 2020 Feb;25(2):172-178. doi: 10.1111/nep.13595. Epub 2019 May 1.
10
Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.多发性骨髓瘤或轻链沉积病导致终末期肾病开始肾脏替代治疗患者的发病率和结局:ERA-EDTA 登记研究。
Nephrol Dial Transplant. 2010 Apr;25(4):1200-6. doi: 10.1093/ndt/gfp679. Epub 2009 Dec 27.

引用本文的文献

1
Patient-reported outcome measures in hemodialysis patients: results of the first multicenter cross-sectional ePROMs study in France.血液透析患者的患者报告结局测量指标:法国首个多中心横断面 ePROMs 研究结果。
BMC Nephrol. 2021 Oct 30;22(1):357. doi: 10.1186/s12882-021-02551-3.

本文引用的文献

1
Survival of South African patients on renal replacement therapy.接受肾脏替代治疗的南非患者的生存率。
Clin Kidney J. 2020 Mar 4;13(5):782-790. doi: 10.1093/ckj/sfaa012. eCollection 2020 Oct.
2
Connecting knowledge with action for health equity: a critical interpretive synthesis of promising practices.将知识与行动联系起来促进健康公平:有前途的实践的批判性解释性综合。
Int J Equity Health. 2019 Dec 26;18(1):202. doi: 10.1186/s12939-019-1108-x.
3
Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey.全球各国和地区终末期肾病护理状况:国际横断面调查。
BMJ. 2019 Oct 31;367:l5873. doi: 10.1136/bmj.l5873.
4
The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016: a summary.欧洲肾脏协会 - 欧洲透析与移植协会(ERA-EDTA)2016年注册报告摘要
Clin Kidney J. 2019 Feb 26;12(5):702-720. doi: 10.1093/ckj/sfz011. eCollection 2019 Oct.
5
A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases.一个用于宣传和沟通的数字——全球超过8.5亿人患有肾脏疾病。
Nephrol Dial Transplant. 2019 Nov 1;34(11):1803-1805. doi: 10.1093/ndt/gfz174.
6
Increasing access to integrated ESKD care as part of universal health coverage.提高获得综合终末期肾病护理的机会,作为全民健康覆盖的一部分。
Kidney Int. 2019 Apr;95(4S):S1-S33. doi: 10.1016/j.kint.2018.12.005.
7
Global coverage of health information systems for kidney disease: availability, challenges, and opportunities for development.全球肾脏疾病健康信息系统的覆盖情况:可用性、挑战与发展机遇
Kidney Int Suppl (2011). 2018 Feb;8(2):74-81. doi: 10.1016/j.kisu.2017.10.011. Epub 2018 Jan 19.
8
Nephrologist Leadership in Advocacy and Public Policy.肾病学家在倡导和公共政策方面的领导作用。
Adv Chronic Kidney Dis. 2018 Nov;25(6):505-513. doi: 10.1053/j.ackd.2018.08.020.
9
Women and renal replacement therapy in Europe: lower incidence, equal access to transplantation, longer survival than men.欧洲女性与肾脏替代治疗:发病率较低、移植机会均等、生存率高于男性。
Clin Kidney J. 2018 Feb;11(1):1-6. doi: 10.1093/ckj/sfx154. Epub 2018 Feb 6.
10
The effect of differing kidney disease treatment modalities and organ donation and transplantation practices on health expenditure and patient outcomes.不同肾脏疾病治疗方式以及器官捐献和移植实践对医疗支出和患者预后的影响。
Nephrol Dial Transplant. 2018 Apr 1;33(4):560-562. doi: 10.1093/ndt/gfx082.

肾脏替代治疗的宣传:肾脏登记处的作用。

Advocacy for renal replacement therapy: the role of renal registries.

作者信息

Couchoud Cecile, Gharbi Mohamed Benghanem

机构信息

REIN Registry, Agence de la biomédecine, Saint Denis La Plaine, France.

Nephrology Department, Faculty of Medicine, University Hassan II, Casablanca, Morocco.

出版信息

Clin Kidney J. 2020 Jul 29;13(5):742-744. doi: 10.1093/ckj/sfaa067. eCollection 2020 Oct.

DOI:10.1093/ckj/sfaa067
PMID:33125002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7577751/
Abstract

The paper by Jardine . reporting results from the South African Renal Registry describes a 2-fold success. First, even in a limited-resource environment, survival of patients on renal replacement therapy (RRT) is favourable. Secondly, this information is available because a few years ago, South African nephrologists started a renal registry. These successes cannot conceal, however, that numerous patients are not offered RRT. Robust health information systems make it possible to define chronic kidney disease and end-stage kidney disease (ESKD) burdens, guide resource allocation, inform service planning and enable policy. Registries can highlight inequitable RRT access and help support advocacy in favour of additional resources for ESKD care.

摘要

贾丁的论文报告了南非肾脏登记处的结果,描述了两方面的成功。首先,即使在资源有限的环境中,接受肾脏替代治疗(RRT)的患者的存活率也很高。其次,之所以能获得这些信息,是因为几年前南非肾病学家启动了一个肾脏登记处。然而,这些成功并不能掩盖众多患者未得到RRT治疗的事实。强大的健康信息系统有助于界定慢性肾脏病和终末期肾病(ESKD)的负担,指导资源分配,为服务规划提供信息并推动政策制定。登记处可以突出RRT获取方面的不公平现象,并有助于支持倡导为ESKD护理争取更多资源。